When it comes to managing and mitigating product development risk, there are six guiding principles that are proven to work.

Monday, 08 June 2020 01:30

MINIFAB rebrands to SCHOTT MINIFAB

Market leader in microfluidic device manufacture has re-branded from MINIFAB to SCHOTT MINIFAB. The change of name and visual re-brand comes after SCHOTT AG acquired the company in July 2019 and forms one part of an ongoing integration process.

Taking a long-term view at the outset of the cartridge development program is critical for reducing the cost of goods (COGS) when the time inevitably comes to ramp up manufacturing volume.

Are you developing a diagnostic microfluidic product? Validating assay maturity is critical for commercial success.

Edward Wilkinson, Vice President of SCHOTT MINIFAB USA and Head of Strategy, explains why a fully integrated bioscience and engineering approach is the key to risk mitigation.

Friday, 20 March 2020 02:45

Delivering Excellence During COVID-19

We are pleased to inform you, our valued customer, that Minifab is very well advanced in its plans to operate during the COVID-19 pandemic. Minifab is built on a culture of innovation. Overcoming the world's most challenging problems is second nature to us. 

Our number one priority is always to the health and safety of our workforce. In this unique environment protecting our workforce also protects you - our customer.